Loading…
NeuroOne Medical Technologies Corporation is projected to rise to $5.34 by 2027, a +43% move from its current price of $3.73. NMTC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.58 | $3.73 | $3.89 | +0.04% |
| May 30 | $3.52 | $3.73 | $3.96 | +0.08% |
| May 31 | $3.47 | $3.73 | $4.02 | +0.12% |
| Jun 1 | $3.43 | $3.74 | $4.07 | +0.17% |
| Jun 2 | $3.40 | $3.74 | $4.11 | +0.21% |
| Jun 3 | $3.37 | $3.74 | $4.15 | +0.25% |
| Jun 4 | $3.34 | $3.74 | $4.18 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.34 | $3.74 | $4.18 | +0.29% |
| Week 2 | $3.20 | $3.75 | $4.40 | +0.58% |
| Week 3 | $3.10 | $3.76 | $4.57 | +0.87% |
| Week 4 | $3.02 | $3.77 | $4.72 | +1.16% |
| Week 5 | $2.95 | $3.78 | $4.86 | +1.46% |
| Week 6 | $2.88 | $3.80 | $4.99 | +1.75% |
| Week 7 | $2.83 | $3.81 | $5.12 | +2.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NeuroOne Medical Technologies Corporation is a medical technology company that provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
The company is based in Eden Prairie, Minnesota, and has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies.
NeuroOne Medical Technologies Corporation (NMTC) is a healthcare stock with a current price of $3.69 and a market capitalization of $31.81M, ranking 4785. The asset operates within the Healthcare sector.
A major floor 26.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.1% away) — a key level to hold.
The nearest ceiling, 37.0% above — a clean break opens room to run.
A major ceiling 50.0% above — clearing it would confirm fresh momentum.
Key NMTC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NMTC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.86 | Sell | $3.88 | Sell |
| MA 10 | $4.12 | Sell | $4.04 | Sell |
| MA 20 | $4.31 | Sell | $4.24 | Sell |
| MA 50 | $4.51 | Sell | $4.44 | Sell |
| MA 100 | $4.69 | Sell | $4.54 | Sell |
| MA 200 | $4.70 | Sell | $4.64 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.84 | Neutral |
| Stoch RSI (14) | 12.45 | Buy |
| CCI (20) | -149.56 | Sell |
| Williams %R (14) | -96.26 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -21.64 | Sell |
| Bollinger %B (20,2) | 0.04 | Neutral |
| Stochastic %K (14) | 3.74 | Buy |
| TRIX (15) | -0.41 | Sell |
| Awesome (5,34) | -0.61 | Sell |
| Ultimate (7,14,28) | 36.84 | Neutral |
| Momentum (10) | -0.66 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 3.64 | Buy |
| ADX (14) | 13.15 | Neutral |
| ATR (14) | 0.18 | Info |
The 30-day technical picture shows a bearish posture: RSI14 is 40. The SMA50 is $4.53 and the SMA200 is $4.71, indicating near-term resistance relative to the current price.
Support is at $3.69 and resistance at $5.11, with a 30-day trading range from $2.78 to $4.91.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.69 | $3.73 | $5.57 | 0% | Neutral | |
| $4.01 | $5.34 | $7.64 | +43% | Bullish | |
| $4.33 | $6.03 | $9.10 | +62% | Bullish | |
| $4.25 | $6.14 | $9.64 | +65% | Bullish | |
| $3.86 | $5.78 | $9.38 | +55% | Bullish | |
| $3.89 | $6.02 | $10.05 | +61% | Bullish | |
| $3.89 | $6.20 | $10.64 | +66% | Bullish | |
| $4.50 | $7.39 | $12.96 | +98% | Bullish | |
| $5.31 | $8.95 | $16.05 | +140% | Bullish | |
| $5.32 | $9.22 | $16.86 | +147% | Bullish | |
| $6.48 | $12.73 | $25.27 | +241% | Bullish | |
| $8.93 | $19.84 | $44.26 | +432% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.69 | $3.73 | $4.46 | +0.00% |
| June 2026 | $3.35 | $3.98 | $4.88 | +6.78% |
| July 2026 | $3.22 | $3.87 | $4.84 | -2.76% |
| August 2026 | $3.19 | $3.89 | $4.94 | +0.35% |
| September 2026 | $3.35 | $4.11 | $5.29 | +5.83% |
| October 2026 | $3.32 | $4.11 | $5.34 | -0.18% |
| November 2026 | $3.20 | $3.98 | $5.23 | -3.02% |
| December 2026 | $3.35 | $4.20 | $5.57 | +5.52% |
Click any year to see its month-by-month NMTC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NMTC price prediction for 2026 points to an average of $3.73 (low $3.69, high $5.57) — a potential gain of 0% on today's $3.73. A consolidation phase looks the most probable path here.
In 2027, NMTC is projected to trade between $4.01 and $7.64, averaging $5.34 — a potential gain of +43% from today's $3.73. That is up +43% on the projected 2026 average. Momentum favours further upside here.
NeuroOne Medical Technologies Corporation's 2028 outlook centres on $6.03, within a $4.33 to $9.10 range. That is up +13% on the projected 2027 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, NMTC could reach as high as $9.64, with a base case around $6.14 and support toward $4.25 — roughly +65% from $3.73. Momentum favours further upside here.
Expect NMTC to range from $3.86 to $9.38 through 2030. The $5.78 average target implies a +55% move from current prices. That is -6% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The NMTC price prediction for 2031 points to an average of $6.02 (low $3.89, high $10.05) — a potential gain of +61% on today's $3.73. Momentum favours further upside here.
In 2032, NMTC is projected to trade between $3.89 and $10.64, averaging $6.20 — a potential gain of +66% from today's $3.73. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
NeuroOne Medical Technologies Corporation's 2033 outlook centres on $7.39, within a $4.50 to $12.96 range. That is up +19% on the projected 2032 average. That marks a +98% change versus current levels. Momentum favours further upside here.
By 2034, NMTC could reach as high as $16.05, with a base case around $8.95 and support toward $5.31 — roughly +140% from $3.73. Buyers look set to stay in control over this stretch.
Expect NMTC to range from $5.32 to $16.86 through 2035. The $9.22 average target implies a +147% move from current prices. That is up +3% on the projected 2034 average. Momentum favours further upside here.
The NMTC price prediction for 2040 points to an average of $12.73 (low $6.48, high $25.27) — a potential gain of +241% on today's $3.73. Buyers look set to stay in control over this stretch.
In 2050, NMTC is projected to trade between $8.93 and $44.26, averaging $19.84 — a potential gain of +432% from today's $3.73. That is up +56% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in NMTC today (≈ 268.096515 NMTC) could be worth
$5,319.6
+$4,319.6 (+432%) by 2050 · US Dollar
Based on the average projected NMTC price of $19.84 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NMTCwould be worth at today's price.
$1,000 invested in NMTC on May 27, 2025 (≈ 272.33116 NMTC) would be worth
$1,015.8
+$15.8 (+1.6%) today · 1.02× · US Dollar
Based on a NMTC entry price of $3.67 vs. today's $3.73.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.09 | $911.98 | -8.8% |
| 1 month ago | $4.61 | $809.11 | -19.1% |
| 3 months ago | $4.15 | $899.66 | -10.0% |
| 6 months ago | $4.17 | $894.48 | -10.6% |
| 1 year ago | $3.67 | $1,015.8 | +1.6% |
| All time (5.0y) ago | $43.47 | $85.81 | -91.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NMTC forecast.
Our base-case forecast reaches $7.50 around 2034.
Implied market cap at $7.50: $64.65M
The multi-year forecast shows a shift from neutral in 2026 to bullish momentum from 2027 onward. The 2027 average price is $5.31 with a max of $7.65 and a min of $3.97 (ROI 44). The 2028 forecast yields an average of $5.96 with a max of $9.04 and a min of $4.26 (ROI 61.6).
The 2029 forecast gives an average of $6.15 (min $4.22, max $9.71, ROI 66.7). In 2030 the average is $5.70 (min $3.78, max $9.31, ROI 54.6), followed by 2031 with an average of $5.94 (min $3.81, max $9.99, ROI 60.9) and 2032 with an average of $6.20 (min $3.86, max $10.71, ROI 68.1).
The trajectory continues to 2033 with an average of $7.27 (min $4.39, max $12.85, ROI 97.1), 2034 with an average of $8.89 (min $5.22, max $16.07, ROI 141.1), and 2035 with an average of $9.25 (min $5.29, max $17.05, ROI 150.8). By 2040, the average is $12.63 (min $6.34, max $25.28, ROI 242.3), and by 2050 the average price is $19.83 (min $8.92, max $44.66, ROI 437.3), with a bullish sentiment throughout those years.
Tap a question to reveal the answer.
2030 min $3.78, avg $5.70, max $9.31, ROI 54.6, sentiment BULLISH.
The forecast shows a transition from neutral in 2026 to bullish from 2027 onward, with 2027 avg $5.31, 2030 avg $5.70, 2050 avg $19.83 and 2050 max $44.66; ROI 437.3. These are estimates, not guarantees.
Yes. The forecast max reaches $10.71 in 2032 and rises in later years to $12.85 (2033) and $16.07 (2034), with further upside by 2040 ($25.28 max) and 2050 ($44.66 max).
Current price is $3.69. For 2026 the min is $3.69, avg $3.69, max $5.62 with sentiment NEUTRAL.
2050 forecast shows avg $19.83, max $44.66, ROI 437.3, sentiment BULLISH.
NeuroOne Medical Technologies Corporation Community Discussion
0Share your NeuroOne Medical Technologies Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.